When a provider prescribes a less expensive drug, what is the expected outcome?

When a provider prescribes a less expensive drug, the expected outcome is increased compliance and reduced financial burden. This choice reflects the understanding that cost is a significant factor influencing a patient's ability to adhere to a treatment regimen. When medications are more affordable, patients are more likely to fill their prescriptions and take their medications as directed, which can lead to better health outcomes.

Reduced financial burden helps alleviate stress and concerns related to healthcare costs. Patients are more inclined to manage their conditions effectively when they don't face insurmountable costs associated with their treatment. Consequently, this can lead to improved compliance, as patients are more likely to stick to their prescribed therapy when it is financially manageable.

In contrast, increased treatment complexity might deter adherence, while decreased patient satisfaction can result from preferences for specific brand-name medications or concerns over efficacy. No significant changes would imply that the choice of medication does not impact treatment, which is not generally the case given the importance of cost considerations in medication adherence. Thus, the relationship between cost and patient behavior underscores the validity of this outcome.